UA105914C2 - Синтез стирилпіридину, міченого радіоізотопом 18f, з тозилатного прекурсора та стабільна фармацевтична композиція на його основі - Google Patents
Синтез стирилпіридину, міченого радіоізотопом 18f, з тозилатного прекурсора та стабільна фармацевтична композиція на його основіInfo
- Publication number
- UA105914C2 UA105914C2 UAA201109307A UAA201109307A UA105914C2 UA 105914 C2 UA105914 C2 UA 105914C2 UA A201109307 A UAA201109307 A UA A201109307A UA A201109307 A UAA201109307 A UA A201109307A UA 105914 C2 UA105914 C2 UA 105914C2
- Authority
- UA
- Ukraine
- Prior art keywords
- radiolabeled
- pharmaceutical compositions
- styrylpyridines
- synthesis
- stable pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000002243 precursor Substances 0.000 title abstract 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- BIAWAXVRXKIUQB-UHFFFAOYSA-N 2-(2-phenylethenyl)pyridine Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=N1 BIAWAXVRXKIUQB-UHFFFAOYSA-N 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Цей винахід належить до методів синтезу міченого радіоізотопом стирилпіридину та його тозилатного прекурсора, зокрема ((E)-4-(2-(6-(2-(2-(2-[F]фтороетоксі)етоксі)етокси)піридин-3-іл)вініл)-N-метилбензенаміну). Цей винахід також належить до стабільних фармацевтичних композицій, що містять мічений радіоізотопом стирилпіридин та 10 % (за об'ємом) етилового спирту і 0,5 % (маса/об'єм) аскорбату натрію.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14188508P | 2008-12-31 | 2008-12-31 | |
PCT/US2009/069741 WO2010078370A1 (en) | 2008-12-31 | 2009-12-29 | Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
UA105914C2 true UA105914C2 (uk) | 2014-07-10 |
Family
ID=42310197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201109307A UA105914C2 (uk) | 2008-12-31 | 2009-12-29 | Синтез стирилпіридину, міченого радіоізотопом 18f, з тозилатного прекурсора та стабільна фармацевтична композиція на його основі |
Country Status (36)
Country | Link |
---|---|
US (1) | US20100172836A1 (uk) |
EP (1) | EP2381967B1 (uk) |
JP (1) | JP5717650B2 (uk) |
KR (1) | KR20110119670A (uk) |
CN (1) | CN102271716B (uk) |
AU (1) | AU2009335049B2 (uk) |
BR (1) | BRPI0923890A2 (uk) |
CA (1) | CA2748705C (uk) |
CO (1) | CO6341578A2 (uk) |
CR (1) | CR20110410A (uk) |
CY (1) | CY1118658T1 (uk) |
DK (1) | DK2381967T3 (uk) |
DO (1) | DOP2011000210A (uk) |
EA (1) | EA023014B1 (uk) |
EC (1) | ECSP11011242A (uk) |
ES (1) | ES2620402T3 (uk) |
HK (1) | HK1162951A1 (uk) |
HN (1) | HN2011001810A (uk) |
HR (1) | HRP20170453T1 (uk) |
HU (1) | HUE033649T2 (uk) |
IL (1) | IL213674A (uk) |
LT (1) | LT2381967T (uk) |
MA (1) | MA33004B1 (uk) |
MX (1) | MX2011007063A (uk) |
MY (1) | MY162312A (uk) |
NZ (1) | NZ593848A (uk) |
PE (1) | PE20120007A1 (uk) |
PL (1) | PL2381967T3 (uk) |
PT (1) | PT2381967T (uk) |
RS (1) | RS55674B1 (uk) |
SG (1) | SG172439A1 (uk) |
SI (1) | SI2381967T1 (uk) |
TN (1) | TN2011000318A1 (uk) |
UA (1) | UA105914C2 (uk) |
WO (1) | WO2010078370A1 (uk) |
ZA (1) | ZA201104824B (uk) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2910945B1 (en) * | 2008-09-30 | 2018-07-18 | Case Western Reserve University | Molecular probes for imaging of myelin |
BR112012030935B1 (pt) | 2010-04-06 | 2020-11-17 | Life Molecular Imaging Sa | método para a produção de ligantes de beta-amiloide marcados com f-18 |
CA2801534A1 (en) | 2010-06-04 | 2011-12-08 | Piramal Imaging Sa | Method for production of f-18 labeled amyloid beta ligand |
TWI504414B (zh) | 2010-06-04 | 2015-10-21 | Bayer Schering Pharma Ag | 生產F-18標記之Aβ配位體之方法 |
CN106729771A (zh) * | 2011-04-21 | 2017-05-31 | 加利福尼亚大学董事会 | 官能化磁性纳米颗粒及在淀粉样沉积物和神经原纤维缠结成像中用途 |
RU2623867C2 (ru) * | 2011-06-21 | 2017-06-29 | Пирамаль Имэджинг Са | Композиции фторированного стильбена, пригодные для пэт визуализации |
EP2768790A1 (en) | 2011-10-19 | 2014-08-27 | Piramal Imaging SA | IMPROVED METHOD FOR PRODUCTION OF F-18 LABELED Aß LIGANDS |
CN102432529B (zh) * | 2011-11-14 | 2014-03-26 | 江苏省原子医学研究所 | 一种苯乙烯基吡啶二硫二氮衍生物的制备方法 |
EP2791113A1 (en) * | 2011-12-15 | 2014-10-22 | GE Healthcare UK Limited | Heterocyclic compounds as imaging probes of tau pathology |
CN102526765B (zh) * | 2011-12-31 | 2014-07-30 | 郑州泰基鸿诺药物科技有限公司 | 一种Aβ斑块显像剂及其制备方法 |
CN103965105A (zh) * | 2013-01-29 | 2014-08-06 | 中山大学 | 苯乙烯基喹啉衍生物及其在治疗阿尔茨海默病症中的应用 |
CN103645254B (zh) * | 2013-11-28 | 2015-01-07 | 江苏省原子医学研究所 | 一种Aβ斑块显像剂前体AV45的含量分析方法 |
WO2017014599A1 (ko) * | 2015-07-22 | 2017-01-26 | 주식회사 씨코헬스케어 | [18f]플루오로-도파의 방사화학적 순도를 안정화시키는 조성물 및 이의 제조방법 |
WO2017083198A1 (en) * | 2015-11-13 | 2017-05-18 | Eli Lilly And Company | Azetidine derivatives for tau imaging |
US10765763B2 (en) | 2016-03-09 | 2020-09-08 | Case Western Reserve University | Radioligands for myelin |
CN107198780A (zh) * | 2016-03-18 | 2017-09-26 | 南京江原安迪科正电子研究发展有限公司 | 放射性药物组合物及其制备方法、应用 |
CN106018575B (zh) * | 2016-05-05 | 2018-10-19 | 江苏省原子医学研究所 | 一种PET显像剂前体TsOP-(+)-DTBZ及其光学异构体的分离测定方法 |
US10695450B2 (en) * | 2016-07-26 | 2020-06-30 | Laboratoires Cyclopharma | Synthesis of a radioactive agent composition |
ES2929277T3 (es) * | 2016-11-08 | 2022-11-28 | Univ California | Métodos para la síntesis multidosis de [F-18]FDDNP para contextos clínicos |
TW201906818A (zh) * | 2017-05-31 | 2019-02-16 | 美商511製藥公司 | 新穎氘取代之正子發射斷層掃描(pet)顯影劑及其藥理應用 |
WO2019145293A1 (en) * | 2018-01-24 | 2019-08-01 | Ac Immune Sa | Diagnostic compositions for pet imaging, a method for manufacturing the diagnostic composition and its use in diagnostics |
CN111499544B (zh) * | 2019-01-31 | 2022-12-02 | 中国医学科学院放射医学研究所 | 一种一锅法制备N-Boc-N-甲基-4-氨基苯乙烯的合成方法 |
CN111499570B (zh) * | 2019-01-31 | 2023-05-16 | 中国医学科学院放射医学研究所 | 一种av-45中间体的合成方法 |
WO2020202831A1 (ja) * | 2019-03-29 | 2020-10-08 | 国立研究開発法人量子科学技術研究開発機構 | 放射性医薬の製造方法及び放射性医薬 |
CN115403434A (zh) * | 2021-05-26 | 2022-11-29 | 汉中汉核医疗科技有限公司 | 一种放射性药物的合成方法 |
CN115400232A (zh) * | 2021-05-26 | 2022-11-29 | 汉中汉核医疗科技有限公司 | 一种放射性药物合成方法 |
CN113582885B (zh) * | 2021-08-30 | 2023-04-21 | 南京克米斯璀新能源科技有限公司 | 一种烷基磺酸钠的生产方法 |
CN114805190A (zh) * | 2022-06-08 | 2022-07-29 | 吉林大学第一医院 | 一种甲基苯胺类Aβ蛋白显像剂的双柱合成方法 |
WO2024107620A1 (en) * | 2022-11-14 | 2024-05-23 | Eli Lilly And Company | Polymorphic forms of florbetapir precursor av-105 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007525211A (ja) * | 2004-01-19 | 2007-09-06 | テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド | パーキンソン病の診断検査 |
SI2213652T1 (sl) * | 2004-12-17 | 2015-03-31 | The Trustees Of The University Of Pennsylvania | Derivati stilbena in njihova uporaba za vezavo in prikaz amiloidnih plakov |
PL2363392T3 (pl) * | 2006-03-30 | 2017-10-31 | Univ Pennsylvania | Styrylopirydynowe pochodne i ich zastosowanie do wiązania i obrazowania płytek amyloidowych |
-
2009
- 2009-12-29 EA EA201170911A patent/EA023014B1/ru not_active IP Right Cessation
- 2009-12-29 MY MYPI2011003056A patent/MY162312A/en unknown
- 2009-12-29 LT LTEP09837135.4T patent/LT2381967T/lt unknown
- 2009-12-29 JP JP2011543721A patent/JP5717650B2/ja active Active
- 2009-12-29 MA MA34065A patent/MA33004B1/fr unknown
- 2009-12-29 RS RS20170117A patent/RS55674B1/sr unknown
- 2009-12-29 PT PT98371354T patent/PT2381967T/pt unknown
- 2009-12-29 SG SG2011048055A patent/SG172439A1/en unknown
- 2009-12-29 CA CA2748705A patent/CA2748705C/en active Active
- 2009-12-29 CN CN200980153414.5A patent/CN102271716B/zh active Active
- 2009-12-29 HU HUE09837135A patent/HUE033649T2/en unknown
- 2009-12-29 ES ES09837135.4T patent/ES2620402T3/es active Active
- 2009-12-29 BR BRPI0923890-5A patent/BRPI0923890A2/pt active Search and Examination
- 2009-12-29 KR KR1020117017636A patent/KR20110119670A/ko not_active Application Discontinuation
- 2009-12-29 MX MX2011007063A patent/MX2011007063A/es active IP Right Grant
- 2009-12-29 NZ NZ593848A patent/NZ593848A/xx unknown
- 2009-12-29 EP EP09837135.4A patent/EP2381967B1/en active Active
- 2009-12-29 WO PCT/US2009/069741 patent/WO2010078370A1/en active Application Filing
- 2009-12-29 UA UAA201109307A patent/UA105914C2/uk unknown
- 2009-12-29 AU AU2009335049A patent/AU2009335049B2/en active Active
- 2009-12-29 US US12/648,869 patent/US20100172836A1/en not_active Abandoned
- 2009-12-29 PE PE2011001294A patent/PE20120007A1/es not_active Application Discontinuation
- 2009-12-29 SI SI200931600A patent/SI2381967T1/sl unknown
- 2009-12-29 DK DK09837135.4T patent/DK2381967T3/en active
- 2009-12-29 PL PL09837135T patent/PL2381967T3/pl unknown
-
2011
- 2011-06-20 IL IL213674A patent/IL213674A/en active IP Right Grant
- 2011-06-24 TN TN2011000318A patent/TN2011000318A1/fr unknown
- 2011-06-29 HN HN2011001810A patent/HN2011001810A/es unknown
- 2011-06-29 ZA ZA2011/04824A patent/ZA201104824B/en unknown
- 2011-06-29 DO DO2011000210A patent/DOP2011000210A/es unknown
- 2011-07-11 CO CO11086470A patent/CO6341578A2/es active IP Right Grant
- 2011-07-29 EC EC2011011242A patent/ECSP11011242A/es unknown
- 2011-07-29 CR CR20110410A patent/CR20110410A/es unknown
-
2012
- 2012-04-12 HK HK12103613.7A patent/HK1162951A1/xx not_active IP Right Cessation
-
2017
- 2017-02-24 CY CY20171100253T patent/CY1118658T1/el unknown
- 2017-03-20 HR HRP20170453TT patent/HRP20170453T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA105914C2 (uk) | Синтез стирилпіридину, міченого радіоізотопом 18f, з тозилатного прекурсора та стабільна фармацевтична композиція на його основі | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
GB0625648D0 (en) | Compounds | |
TW201713640A (en) | Bruton's tyrosine kinase inhibitors | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
MX2012007098A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
EP2576578A4 (en) | POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF | |
MX2011011797A (es) | Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides. | |
MY148948A (en) | Catecholamine derivatives and prodrugs thereof | |
EA201001682A1 (ru) | Производные фенил- и бензодиоксинилзамещенных индазолов | |
WO2007125103A3 (en) | Benzamide glucokinase activators | |
MX2012007161A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
MX2019012939A (es) | Formulaciones que contienen linaclotida para administracion oral. | |
TW200716568A (en) | 1H-quinazoline-2,4-diones | |
TW200942535A (en) | Novel compounds as cannabinoid receptor ligands | |
TW200745122A (en) | New compounds I | |
TW200738627A (en) | Trialkylsilyl-indoles | |
MX2010010597A (es) | Procesos para la preparacion de derivados de dioxina benzofusionados. | |
UA97965C2 (uk) | Заміщені піразоли, композиція, що їх містить, спосіб їх одержання і застосування | |
IN2011KN05169A (uk) | ||
WO2010077730A3 (en) | Indanone inhibitors of acetylcholinesterase | |
UA111173C2 (uk) | Рідкі композиції, що утворюють покриття, які мають антивірусні властивості | |
RS53002B (en) | ANTI-CANCER UNIT AND PHARMACEUTICAL COPMOSITION CONTAINING IT | |
MX2012007097A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
MX2009006411A (es) | Inhibidores selectivos de enzimas que degradan neurotensina. |